ZFYVE9P1: A Potential Drug Target and Biomarker (G100289259)

ZFYVE9P1: A Potential Drug Target and Biomarker

ZFYVE9P1, also known as ZFYP1, is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the Z-fusin gene family, which is known for its role in cell-cell adhesion and signaling. ZFYVE9P1 has been identified as a potential drug target and biomarker due to its unique structure and expression pattern in various tissues.

Structure and Function

The ZFYVE9P1 protein is a 21-kDa transmembrane protein that consists of an N-terminal cytoplasmic domain, a transmembrane region, and an C-terminal Z-fusin domain. The Z-fusin domain is the protein's most distinctive feature, as it contains a conserved Z-fusin-like domain that is involved in protein-protein interactions and signaling.

ZFYVE9P1 is expressed in a variety of tissues, including the brain, heart, and kidneys, and its expression pattern is highly dependent on the specific tissue type. For example, high levels of ZFYVE9P1 are observed in the brain, while lower levels are found in the heart and kidneys. This differential expression pattern suggests that ZFYVE9P1 may play a unique role in the development and maintenance of various tissues.

In addition to its expression pattern, ZFYVE9P1 has been shown to play a role in several cellular processes. For example, it has been shown to be involved in cell adhesion, migration, and the regulation of ion channels. ZFYVE9P1 has also been shown to interact with several other proteins, including Z-fusin-like proteins, neurotransmitter receptors, and cell surface molecules.

Drug Target Potential

ZFYVE9P1's unique structure and expression pattern, as well as its involvement in several cellular processes, make it an attractive drug target. Several studies have suggested that ZFYVE9P1 may be a good candidate for small molecule inhibitors, particularly those that target the Z-fusin domain.

One potential mechanism by which ZFYVE9P1 could be targeted by small molecules is through its interaction with the Z-fusin domain. The Z-fusin domain is known to have a unique topology that allows it to interact with other proteins and molecules. By modifying the Z-fusin domain, small molecules could potentially disrupt its function and reduce its activity.

Another potential mechanism by which ZFYVE9P1 could be targeted by small molecules is through its role in cell adhesion and migration. ZFYVE9P1 has been shown to be involved in these processes, and small molecules that disrupt its function could potentially lead to the dissociation of cells from the extracellular matrix and the inhibition of their migration.

Biomarker Potential

In addition to its potential as a drug target, ZFYVE9P1 has also been identified as a potential biomarker for several diseases, including cancer, neurodegenerative diseases, and cardiovascular disease. The ZFYVE9P1 protein is expressed in a variety of tissues, including those affected by these diseases, which suggests that it may be a useful biomarker for the detection and diagnosis of these conditions.

For example, ZFYVE9P1 has been shown to be overexpressed in several types of cancer, including breast, ovarian, and prostate cancer. By using ZFYVE9P1 as a biomarker for these conditions, researchers may be able to develop new diagnostic tests or therapeutic treatments.

Conclusion

ZFYVE9P1 is a protein that has unique structure and function, and its expression pattern and involvement in several cellular processes make it an attractive candidate for drug targeting and biomarker development. The Z-fusin domain's conserved topology and its involvement in cell adhesion, migration, and the regulation of ion channels suggest that small molecules may be able to modify its function and disrupt its activity. Further research is needed to determine the full potential of ZFYVE9P1 as a drug target and biomarker.

Protein Name: Zinc Finger FYVE-type Containing 9 Pseudogene 1

The "ZFYVE9P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZFYVE9P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P